Mosanna Therapeutics
Mosanna Therapeutics' first goal is to bring an effective and well-tolerated medicinal nasal spray to Metabolic Obstructive Sleep Apnea (MOSA) patients.
Mosanna Therapeutics has raised €70M across 2 funding rounds from 6 investors, most recently a Series A round in Jun 2025. Based in Zurich, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Zurich, Switzerlandmosanna.com ↗
Total raised
€70M
€69,997,375
Funding rounds
2
Investors
6
distinct backers
Active since
2022-07
latest 2025-06
Funding by year
EUR raised per yearMosanna Therapeutics — funding by year — interactive chart.
Data table
| Mosanna Therapeutics — funding by year | |
|---|---|
| 2022 | €0 |
| 2025 | €70M |
Signals
Medium confidenceRaise-next likelihood63
base rate 44% for Series A
- ▲ In typical raise window
- ▼ Low backer re-investment
Exit likelihood22
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ Recently backed by strong-exit-track investors
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-06-10 | Series A | €70M | Broadview Ventures,EQT Life Sciences,Forbion,Norwest Venture Partners,Pivotal bioVenture Partners | View deal → |
| 2022-07-15 | Seed | — | Forty51 Ventures | View deal → |
Investors
6Related news
- Mosanna Therapeutics completes seed roundstartupticker.ch · 2022-07
- siliconcanals.com
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData